Clinical Trial Update: Safety Evaluation of Linear and Macrocyclic Gadolinium Based Contrast Agents for Patients With Mild to Moderate Renal Insufficiency Undergoing Enhanced Magnetic Resonance Imaging [Phase 4]

View source ↗

Summary

A Phase 4 safety evaluation trial assessing linear and macrocyclic gadolinium-based contrast agents in patients with mild to moderate renal insufficiency underg…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nephrogenic Fibrosing Dermopathy

Snippet

Sponsor: The Central Hospital of Lishui City | Conditions: Nephrogenic Fibrosing Dermopathy | Phase 4 | Status: UNKNOWN